Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 93.73% is 41% above its 5-year average of 66.63%, near the high end of its 5-year range (0.00%–100.00%).
0.99% above its 12-month average of 92.81%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 95.97%.
GROSS MARGIN
93.73%
GROSS MARGIN AVG TTM
92.81%
GROSS MARGIN AVG 3Y
93.69%
GROSS MARGIN AVG 5Y
66.63%
GROSS MARGIN AVG 10Y
36.56%
GROSS MARGIN AVG 15Y
24.58%
GROSS MARGIN AVG 20Y
0.00%
CURRENT VS TTM AVG
+0.99%
CURRENT VS 3Y AVG
+0.04%
CURRENT VS 5Y AVG
+40.68%
CURRENT VS 10Y AVG
+156.34%
CURRENT VS 15Y AVG
+281.39%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
42.92%
median of 605 covered companies
CURRENT VS SECTOR MEDIAN
+118.38%
vs the sector median at left
Fennec Pharmaceuticals Inc.
Market Cap
$352.93M
Gross Margin
93.73%
TTM Avg
92.81%
3Y Avg
93.69%
5Y Avg
66.63%
Market Cap
$355.99M
Gross Margin
99.32%
TTM Avg
95.85%
3Y Avg
93.96%
5Y Avg
99.79%
Market Cap
$349.23M
Gross Margin
98.15%
TTM Avg
96.49%
3Y Avg
98.25%
5Y Avg
98.83%
Market Cap
$347.70M
Gross Margin
99.87%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
83.33%
Market Cap
$342.13M
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
75.00%
5Y Avg
66.67%
Market Cap
$370.48M
Gross Margin
25.47%
TTM Avg
27.02%
3Y Avg
15.55%
5Y Avg
5.84%
Market Cap
$376.93M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
40.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fennec Pharmaceuticals Inc. (FENC) | $352.93M | 93.73% | 92.81% | 93.69% | 66.63% |
| Ocugen, Inc. (OCGN)vs › | $354.37M | 45.86% | 48.66% | 71.42% | -2398.51% |
| Embecta Corp. (EMBC)vs › | $354.19M | 59.89% | 63.90% | 65.83% | 67.05% |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $355.99M | 99.32% | 95.85% | 93.96% | 99.79% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $349.23M | 98.15% | 96.49% | 98.25% | 98.83% |
| Opus Genetics, Inc. (IRD)vs › | $347.70M | 99.87% | 100.00% | 100.00% | 83.33% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $342.13M | 0.00% | 50.00% | 75.00% | 66.67% |
| Canopy Growth Corporation (CGC)vs › | $370.48M | 25.47% | 27.02% | 15.55% | 5.84% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $376.93M | 0.00% | 0.00% | 25.00% | 40.00% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $332.73M | 62.61% | 61.15% | 61.24% | 64.05% |
Gross Margin
93.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 95.97% |
| 2026-03-31 | 96.23% |
| 2025-12-31 | 87.20% |
| 2025-09-30 | 94.70% |
| 2025-06-30 | 89.98% |
| 2025-03-31 | 95.74% |
| 2024-12-31 | 91.56% |
| 2024-09-30 | 80.54% |
| 2024-06-30 | 91.63% |
| 2024-03-31 | 97.83% |
| 2023-12-31 | 92.96% |
| 2023-09-30 | 94.92% |
| 2023-06-30 | 95.55% |
| 2023-03-31 | 94.34% |
| 2022-12-31 | 100.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 100.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
